Search research articles
Contact Us
Filters
Showing results (131-140 of 202) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Bladder cancer: narrowing the gap between evidence and practice
Maha H A Hussain, David P Wood, Dean F Bajorin, et al.
World Journal of Urology
|
August 20, 2015
Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy
Kamran Zargar-Shoshtari, Homayoun Zargar, Colin P Dinney, et al.
BMJ (Clinical Research Ed.)
|
February 2, 2018
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Huakang Tu, Chi Pang Wen, Shan Pou Tsai, et al.
World Journal of Urology
|
May 28, 2018
Salvage topical therapy for upper tract urothelial carcinoma
Adithya Balasubramanian, Michael J Metcalfe, Gavin Wagenheim, et al.
Oncoimmunology
|
May 10, 2019
Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
Devin Plote, Woonyoung Choi, Sharada Mokkapati, et al.
The Journal of Urology
|
January 17, 2012
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial
Ashish M Kamat, Rian J Dickstein, Fabrizio Messetti, et al.
BJU International
|
July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin
Roberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Cancer Research
|
October 18, 2002
Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel
Samuel F Huang, Sun-Jin Kim, Anh T Lee, et al.
Urologic Oncology
|
November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
Patrick J Hensley, Zhigang Duan, Kelly Bree, et al.
World Journal of Urology
|
March 14, 2019
The role of metastatic burden in cytoreductive/consolidative radical cystectomy
Roger Li, Janet E Baack Kukreja, Mohamed A Seif, et al.
Page
of 21
Search research articles
Search
Showing results (131-140 of 202) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 28, 2009
Bladder cancer: narrowing the gap between evidence and practice
Maha H A Hussain, David P Wood, Dean F Bajorin, et al.
World Journal of Urology
|
August 20, 2015
Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy
Kamran Zargar-Shoshtari, Homayoun Zargar, Colin P Dinney, et al.
BMJ (Clinical Research Ed.)
|
February 2, 2018
Cancer risk associated with chronic diseases and disease markers: prospective cohort study
Huakang Tu, Chi Pang Wen, Shan Pou Tsai, et al.
World Journal of Urology
|
May 28, 2018
Salvage topical therapy for upper tract urothelial carcinoma
Adithya Balasubramanian, Michael J Metcalfe, Gavin Wagenheim, et al.
Oncoimmunology
|
May 10, 2019
Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation
Devin Plote, Woonyoung Choi, Sharada Mokkapati, et al.
The Journal of Urology
|
January 17, 2012
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial
Ashish M Kamat, Rian J Dickstein, Fabrizio Messetti, et al.
BJU International
|
July 13, 2023
Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin
Roberto Contieri, Valentina Grajales, Wei Shen Tan, et al.
Cancer Research
|
October 18, 2002
Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel
Samuel F Huang, Sun-Jin Kim, Anh T Lee, et al.
Urologic Oncology
|
November 20, 2022
Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship
Patrick J Hensley, Zhigang Duan, Kelly Bree, et al.
World Journal of Urology
|
March 14, 2019
The role of metastatic burden in cytoreductive/consolidative radical cystectomy
Roger Li, Janet E Baack Kukreja, Mohamed A Seif, et al.
Page
of 21